Nomura Holdings’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $950K | Sell |
3,307
-1,026
| -24% | -$295K | ﹤0.01% | 460 |
|
2025
Q1 | $1.34M | Sell |
4,333
-1,591
| -27% | -$490K | ﹤0.01% | 583 |
|
2024
Q4 | $2.09M | Buy |
+5,924
| New | +$2.09M | ﹤0.01% | 595 |
|
2024
Q3 | – | Sell |
-792
| Closed | -$252K | – | 1341 |
|
2024
Q2 | $252K | Buy |
+792
| New | +$252K | ﹤0.01% | 894 |
|
2021
Q2 | – | Sell |
-6,250
| Closed | -$1.05M | – | 1855 |
|
2021
Q1 | $1.05M | Buy |
+6,250
| New | +$1.05M | ﹤0.01% | 746 |
|
2018
Q4 | – | Sell |
-1,625
| Closed | -$205K | – | 952 |
|
2018
Q3 | $205K | Sell |
1,625
-3,480
| -68% | -$439K | ﹤0.01% | 802 |
|
2018
Q2 | $578K | Buy |
+5,105
| New | +$578K | ﹤0.01% | 625 |
|
2018
Q1 | – | Sell |
-11,621
| Closed | -$1.72M | – | 1144 |
|
2017
Q4 | $1.72M | Buy |
11,621
+4,791
| +70% | +$709K | ﹤0.01% | 521 |
|
2017
Q3 | $802K | Buy |
6,830
+3,724
| +120% | +$437K | ﹤0.01% | 675 |
|
2017
Q2 | $403K | Buy |
+3,106
| New | +$403K | ﹤0.01% | 885 |
|
2017
Q1 | – | Sell |
-3,325
| Closed | -$472K | – | 1094 |
|
2016
Q4 | $472K | Buy |
+3,325
| New | +$472K | ﹤0.01% | 780 |
|
2016
Q3 | – | Sell |
-2,149
| Closed | -$227K | – | 904 |
|
2016
Q2 | $227K | Sell |
2,149
-2,090
| -49% | -$221K | ﹤0.01% | 594 |
|
2016
Q1 | $479K | Sell |
4,239
-7
| -0.2% | -$791 | ﹤0.01% | 526 |
|
2015
Q4 | $666K | Sell |
4,246
-301
| -7% | -$47.2K | ﹤0.01% | 547 |
|
2015
Q3 | $600K | Sell |
4,547
-8,581
| -65% | -$1.13M | ﹤0.01% | 545 |
|
2015
Q2 | $2.28M | Buy |
+13,128
| New | +$2.28M | 0.01% | 505 |
|
2014
Q3 | – | Sell |
-9,339
| Closed | -$833K | – | 2099 |
|
2014
Q2 | $833K | Buy |
9,339
+7,194
| +335% | +$642K | ﹤0.01% | 843 |
|
2014
Q1 | $202K | Sell |
2,145
-1,759
| -45% | -$166K | ﹤0.01% | 1613 |
|
2013
Q4 | $441K | Sell |
3,904
-11,820
| -75% | -$1.34M | ﹤0.01% | 1236 |
|
2013
Q3 | $1.24M | Sell |
15,724
-28,191
| -64% | -$2.22M | 0.01% | 912 |
|
2013
Q2 | $2.89M | Buy |
+43,915
| New | +$2.89M | 0.02% | 437 |
|